Abstract
Introduction: Genome-wide association studies (GWASs) often adjust for covariates, correct for medication use, or select on medication users. If these summary statistics are used in two-sample Mendelian randomization analyses, estimates may be biased. We used simulations to investigate how GWAS adjustment, correction and selection affects these estimates and performed an analysis in UK Biobank to provide an empirical example. Methods: We simulated six GWASs: no adjustment for a covariate, correction for medication use, or selection on medication users; adjustment only; selection only; correction only; both adjustment and selection; and both adjustment and correction. We then ran two-sample Mendelian randomization analyses using these GWASs to evaluate bias. We also performed equivalent GWASs using empirical data from 306,560 participants in UK Biobank with systolic blood pressure as the exposure and body mass index as the covariate and ran two-sample Mendelian randomization with coronary heart disease as the outcome. Results: The simulation showed that estimates from GWASs with selection can produce biased two-sample Mendelian randomization estimates. Yet, we observed relatively little difference between empirical estimates of the effect of systolic blood pressure on coronary artery disease across the six scenarios. Conclusions: Given the potential for bias from using GWASs with selection on Mendelian randomization estimates demonstrated in our simulation, careful consideration before using this approach is warranted. However, based on our empirical results, using adjusted, corrected or selected GWASs is unlikely to make a large difference to two-sample Mendelian randomization estimates in practice.
Highlights
Genome-wide association studies (GWASs) often adjust for covariates, correct for medication use, or select on medication users
We found selection on medication users led to a point estimate of the beta that was 47% greater than the simulated true effect of unmeasured exposure phenotype on the outcome phenotype across effect sizes
The combination of adjustment for a covariate and selection on medication users led to an overestimate of the beta of 41%
Summary
Genome-wide association studies (GWASs) often adjust for covariates, correct for medication use, or select on medication users If these summary statistics are used in two-sample Mendelian randomization analyses, estimates may be biased. Two-sample Mendelian randomization is a popular causal inference method that uses summary statistics from two GWASs to assess the effect of an exposure, obtained from one GWAS, on an outcome, obtained from the second GWAS1–3 GWASs are often adjusted for covariates, corrected for medication use, or selected on medication users to maximise power and avoid potential biases from factors that are not the phenotype of interest While these practices are often beneficial for GWASs, they may affect the SNP-phenotype associations and may cause bias in two-sample Mendelian randomization analyses[4]. The aim of this study was to assess the consequences of three common GWAS alterations and, where appropriate, their combination on two-sample Mendelian randomization estimates:
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.